Reuters logo
BRIEF-Allergy says investigating dosing of PQ grass receives CTA approval
September 18, 2017 / 6:19 AM / 3 months ago

BRIEF-Allergy says investigating dosing of PQ grass receives CTA approval

Sept 18 (Reuters) - Allergy Therapeutics Plc:

* SAYS THAT FULLY-FUNDED PHASE II CLINICAL TRIAL INVESTIGATING DOSING OF PQ GRASS HAS RECEIVED CLINICAL TRIAL APPLICATION (CTA) APPROVAL Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below